GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

By Engmann Lawrence   Benadiva Claudio  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3258-3260

Oxford University Press

Access to resources Recommend Favorite

GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

By Humaidan P.  

Human Reproduction, Vol. 20, Iss. 5, 2005-05 ,pp. : 1213-1220

Oxford University Press

Access to resources Recommend Favorite

Reply: GnRH agonist (buserelin) or hCG for ovulation induction in gnRH antagonist IVF/ICSI cycles: a prospective randomized study

By Humaidan Peter  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3260-3260

Oxford University Press

Access to resources Recommend Favorite

Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy

By Huirne Judith A.F.   van Loenen Andre C.D.   Schats Roel   McDonnell Joseph   Hompes Peter G.A.   Schoemaker Joop   Homburg Roy   Lambalk Cornelis B.  

Human Reproduction, Vol. 20, Iss. 2, 2005-02 ,pp. : 359-367

Oxford University Press

Access to resources Recommend Favorite

A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates

By Lahoud R.   Jefout M.Al   Tyler J.   Ryan J.   Driscoll G.  

Human Reproduction, Vol. 21, Iss. 10, 2006-10 ,pp. : 2645-2649

Oxford University Press

Access to resources Recommend Favorite